Comparison of the PrimAry Long Versus Short Coverage With Drug-Eluting Stents for Long FemoRopopliteal Artery DiseasE (PARADE II): Investigator-initiated Clinical Study

Femoropopliteal Artery Disease Clinical Trial

Status Recruiting

Clinical Trial Summary

- Prospective, randomized, controlled, multi-center study

- A total of 220 subjects with long femoropopliteal lesions will be included according to inclusion and exclusion criteria.

- Patients will be randomized in a 1:1 manner into long stenting group versus short stenting group. and treated with Zilver PTX for long femoropopliteal lesions

- Patients will be followed clinically for 1 year after the procedure.

- Image study follow-up (Duplex US or CT angiography) will be performed at 1 year.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Femoropopliteal Artery Disease

Clinical Trial Details

NCT number	NCT02701881
Study type	Interventional
Source	Yonsei University
Contact
Status	Recruiting
Phase	Phase 4
Start date	January 2016
Completion date	August 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02145065` - First-in-man Evaluation of a Novel, Microcrystalline Paclitaxel Coated Balloon for Treatment of Femoropopliteal Artery Disease (PAX-r)	N/A
Recruiting	`NCT05307263` - Combination Therapy of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon for Complex Femoropopliteal Artery Disease	N/A
Completed	`NCT03517904` - Comparison of Intravascular Ultrasound-Guided vs. Angiography-guided Angioplasty and Dual-antiplatelet v. Triple-antiplatelet Therapy for Outcomes of Drug-coated Balloon in the Treatment of Femoropopliteal Artery Disease (IVUS-DCB)	N/A
Recruiting	`NCT02701816` - Korean Multicenter Registry of INNOVA Stent for Femoropopliteal Artery Disease: (K-INNOVA Registry)